Seattle WA (SPX) Mar 19, 2019Acucela Inc has signed an agreement with the Translational Research Institute for Space Health (TRISH) to develop a compact OCT*1 device for NASA's Deep Space missions. Approximately 63% of long-duration spaceflight crewmembers present with one or more signs of Spaceflight Associated Neuro-ocular Syndrome (SANS), including optic disc edema, globe flattening, choroidal folds, cotton wool sp